Researchers have proven that antibiotic-resistant strains of a harmful bacteria thrive in a diabetic infection environment. Antibiotics are powerful, fast-acting medications designed to eradicate ...

Novel oral GRK2-biased β2 adrenergic receptor agonists show potential for safer glucose management and obesity treatment.

The evolution of diabetes treatment has unveiled a surprising discovery in cardiovascular health. Semaglutide, commonly known by brand names like Ozempic, Wegovy, and Rybelsus, has demonstrated ...

The number of Americans with type 2 diabetes and/or obesity is rising, and the entry of therapies such as glucagon-like peptide-1 (GLP-1) receptor agonists has been revolutionary. In this landscape, ...

Diabetes is a chronic disease characterised by a failure of insulin to control blood glucose levels with two main types: type 1 and type 2. Diabetes is a global concern, with 783 million adults ...

Experts convened in Cleveland, Ohio, on November 11, 2025, to discuss the evolution of cardio-renal-metabolic care from ...

People diagnosed with Type 1 diabetes before age 10 often face a shorter life expectancy. For Orange native Frank McCoy, that prediction didn’t hold true. McCoy was diagnosed with Type 1 diabetes when ...

Antibiotics are powerful, fast-acting medications designed to eradicate bacterial infections. However, in recent years, their dependability has waned as antibiotic resistant bacteria continues to ...

Antibiotics are powerful, fast-acting medications designed to eradicate bacterial infections. However, in recent years, their dependability has waned as antibiotic resistant bacteria continues to ...